Free Trial
NASDAQ:ONC

BeOne Medicines 5/7/2025 Earnings Report

BeOne Medicines logo
$299.01 -2.12 (-0.70%)
As of 08/1/2025 04:00 PM Eastern

BeOne Medicines EPS Results

Actual EPS
$1.22
Consensus EPS
-$0.71
Beat/Miss
Beat by +$1.93
One Year Ago EPS
N/A

BeOne Medicines Revenue Results

Actual Revenue
$1.12 billion
Expected Revenue
$1.12 billion
Beat/Miss
Missed by -$7.30 million
YoY Revenue Growth
N/A

BeOne Medicines Announcement Details

Quarter
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

BeOne Medicines' next earnings date is scheduled for Wednesday, August 6, 2025.

Conference Call Resources

BeOne Medicines Earnings Headlines

BeOne Medicines' Tevimbra Gets CHMP Positive Opinion
Is Elon's empire crumbling?
The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.
Wall Street Zen Upgrades BeOne Medicines (NASDAQ:ONC) to "Buy"
See More BeOne Medicines Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like BeOne Medicines? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BeOne Medicines and other key companies, straight to your email.

About BeOne Medicines

BeOne Medicines (NASDAQ:ONC) Ltd. is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. The firm portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in Basel, Switzerland.

View BeOne Medicines Profile

More Earnings Resources from MarketBeat